Basic Information
Scope Biosciences is a Dutch company specializing in the development of molecular diagnostic technologies using CRISPR-Cas. It is a spin-off from Wageningen University & Research, founded in 2020 by Jurre Steens, Niek Savelkoul, Bart Scholten, and Stijn Prinsen. They are supported by experienced entrepreneurs Math Kohnen and Wil Hazenberg. The idea for founding Scope Biosciences originated from close collaboration with the Microbiology Laboratory of the Department of Agrotechnology and Food Sciences at Wageningen University. Van der Oost and Staals are both co-founders and will continue to act as scientific advisors, supporting Scope Biosciences. The ScopeDx technology was co-developed with Wageningen University & Research and exclusively licensed to Scope Biosciences.